Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Verani

Showing results (121-130 of 259) with videos related to

Pageof 26
Sort By:
The Pediatric Infectious Disease Journal|June 9, 2016
Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South AfricaJennifer R Verani, Michelle J Groome, Heather J Zar, et al.
Plos One|January 7, 2014
Surveillance for hospitalized acute respiratory infection in GuatemalaJennifer R Verani, John McCracken, Wences Arvelo, et al.
BMC Health Services Research|June 6, 2018
Evaluation of the impact of the ARC program on national nursing and midwifery regulations, leadership, and organizational capacity in East, Central, and Southern AfricaJessica M Gross, Carey F McCarthy, Andre R Verani, et al.
The Journal of Infectious Diseases|March 3, 2026
The age-specific concentrations and seroprevalence of antibodies against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) across three sites in KenyaEsther M Muthumbi, Sean C Elias, Alfred Mwanzu, et al.
Vaccine|October 3, 2019
Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern MozambiqueSérgio Massora, Fernanda C Lessa, Benild Moiane, et al.
The Journal of Infectious Diseases|September 21, 2025
PEPFAR Investments in National Public Health Institutes: HIV Control Through Strong SystemsAndre R Verani, Eduardo Samo Gudo, Roma Chilengi, et al.
The Lancet. Respiratory Medicine|April 15, 2014
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control studyCarla Magda Allan S Domingues, Jennifer R Verani, Ernesto Issac Montenegro Renoiner, et al.
The Pediatric Infectious Disease Journal|September 15, 2018
Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in MozambiqueBetuel Sigaúque, Benild Moiane, Sergio Massora, et al.
Journal of the Pediatric Infectious Diseases Society|November 27, 2020
Effect of 10-Valent Pneumococcal Conjugate Vaccine on Streptococcus pneumoniae Nasopharyngeal Carriage Among Children Less Than 5 Years Old: 3 Years Post-10-Valent Pneumococcal Conjugate Vaccine Introduction in MozambiqueSandra J Valenciano, Benild Moiane, Fernanda C Lessa, et al.
Vaccine|October 4, 2016
Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, BrazilMaria-Cristina de C Brandileone, Rosemeire C Zanella, Samanta C G Almeida, et al.
Pageof 26

Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
The Pediatric Infectious Disease Journal|June 9, 2016
Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South AfricaJennifer R Verani, Michelle J Groome, Heather J Zar, et al.
Plos One|January 7, 2014
Surveillance for hospitalized acute respiratory infection in GuatemalaJennifer R Verani, John McCracken, Wences Arvelo, et al.
BMC Health Services Research|June 6, 2018
Evaluation of the impact of the ARC program on national nursing and midwifery regulations, leadership, and organizational capacity in East, Central, and Southern AfricaJessica M Gross, Carey F McCarthy, Andre R Verani, et al.
The Journal of Infectious Diseases|March 3, 2026
The age-specific concentrations and seroprevalence of antibodies against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) across three sites in KenyaEsther M Muthumbi, Sean C Elias, Alfred Mwanzu, et al.
Vaccine|October 3, 2019
Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern MozambiqueSérgio Massora, Fernanda C Lessa, Benild Moiane, et al.
The Journal of Infectious Diseases|September 21, 2025
PEPFAR Investments in National Public Health Institutes: HIV Control Through Strong SystemsAndre R Verani, Eduardo Samo Gudo, Roma Chilengi, et al.
The Lancet. Respiratory Medicine|April 15, 2014
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control studyCarla Magda Allan S Domingues, Jennifer R Verani, Ernesto Issac Montenegro Renoiner, et al.
The Pediatric Infectious Disease Journal|September 15, 2018
Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in MozambiqueBetuel Sigaúque, Benild Moiane, Sergio Massora, et al.
Journal of the Pediatric Infectious Diseases Society|November 27, 2020
Effect of 10-Valent Pneumococcal Conjugate Vaccine on Streptococcus pneumoniae Nasopharyngeal Carriage Among Children Less Than 5 Years Old: 3 Years Post-10-Valent Pneumococcal Conjugate Vaccine Introduction in MozambiqueSandra J Valenciano, Benild Moiane, Fernanda C Lessa, et al.
Vaccine|October 4, 2016
Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, BrazilMaria-Cristina de C Brandileone, Rosemeire C Zanella, Samanta C G Almeida, et al.
Pageof 26